Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SENL-B19 by Hebei Senlang Biotechnology for Lymphoma: Likelihood of Approval
SENL-B19 is under clinical development by Hebei Senlang Biotechnology and currently in Phase II for Lymphoma. According to GlobalData, Phase...
SENL-B19 by Hebei Senlang Biotechnology for Non-Hodgkin Lymphoma: Likelihood of Approval
SENL-B19 is under clinical development by Hebei Senlang Biotechnology and currently in Phase II for Non-Hodgkin Lymphoma. According to GlobalData,...
SENL-B19 by Hebei Senlang Biotechnology for Leukemia: Likelihood of Approval
SENL-B19 is under clinical development by Hebei Senlang Biotechnology and currently in Phase II for Leukemia. According to GlobalData, Phase...